MAI Wealth Advisors »

Vistagen Therapeutics Ord shares owned by MAI Wealth Advisors

Quarter-by-quarter ownership of Vistagen Therapeutics Ord (VTGN) shares owned by MAI Wealth Advisors from 13F filings

Historical chart of MAI Wealth Advisors investment in Vistagen Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Vistagen Therapeutics Ord held by MAI Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vistagen Therapeutics Ord by MAI Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $349 526 0.66
2025-09-30 $1.9k 526 3.55
2025-06-30 $1.1k 526 2.00
2025-03-31 $1.4k 576 2.50
2024-12-31 $1.8k 609 2.95

More positions owned by MAI Wealth Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Call Call Option (Principal) (SPY)
Apple Call Call Option (Principal) (AAPL)
Microsoft Corp Call Call Option (Principal) (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Call Call Option (Principal) (GOOGL)
Amazon Call Call Option (Principal) (AMZN)
Invesco Qqq Tr Call Call Option (Principal) (QQQ)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr S&p 500 Val Etf (IVE)
Broadcom Call Call Option (Principal) (AVGO)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for MAI Wealth Advisors

Top funds holding Vistagen Therapeutics Ord

Henderson Group
OrbiMed Advisors
TCG Crossover Management
Vanguard Group
Susquehanna International
ADAR1 Capital Management
Stempoint Capital
Jane Street
Ikarian Capital
Citadel Advisors
BlackRock
Geode Capital Management
Luminus Management
Two Sigma Investments
Jpmorgan Chase & Co

View all funds holding Vistagen Therapeutics Ord